Raymond Anton to Patient Compliance
This is a "connection" page, showing publications Raymond Anton has written about Patient Compliance.
Connection Strength
0.383
-
What role does measuring medication compliance play in evaluating the efficacy of naltrexone? Alcohol Clin Exp Res. 2007 Apr; 31(4):596-603.
Score: 0.228
-
Naltrexone and cognitive behavioral therapy for the treatment of alcohol dependence: do sex differences exist? Alcohol Clin Exp Res. 2008 May; 32(5):771-6.
Score: 0.061
-
Naltrexone and cognitive behavioral therapy for the treatment of outpatient alcoholics: results of a placebo-controlled trial. Am J Psychiatry. 1999 Nov; 156(11):1758-64.
Score: 0.034
-
New methodologies for pharmacological treatment trials for alcohol dependence. Alcohol Clin Exp Res. 1996 Oct; 20(7 Suppl):3A-9A.
Score: 0.027
-
Topiramate for treating alcohol dependence: a randomized controlled trial. JAMA. 2007 Oct 10; 298(14):1641-51.
Score: 0.015
-
A double-blind evaluation of gabapentin on alcohol effects and drinking in a clinical laboratory paradigm. Alcohol Clin Exp Res. 2007 Feb; 31(2):221-7.
Score: 0.014
-
Lithium treatment of depressed and nondepressed alcoholics. JAMA. 1989 Sep 22-29; 262(12):1646-52.
Score: 0.004